148 related articles for article (PubMed ID: 36332221)
1. A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures.
Wang J; Huang J; Peng S; Li L; Zhong K; Chen T
J Infect Dev Ctries; 2022 Oct; 16(10):1650-1654. PubMed ID: 36332221
[TBL] [Abstract][Full Text] [Related]
2. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Wallace RJ; Swenson JM; Silcox VA; Bullen MG
J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Treatment Outcomes of Mycobacterium fortuitum Pulmonary Disease.
Kim SR; Yu JY; Kim SY; Kim DH; Jhun BW
Microbiol Spectr; 2023 Aug; 11(4):e0205123. PubMed ID: 37428038
[TBL] [Abstract][Full Text] [Related]
6. Complicated skin and soft tissue infection with Mycobacterium fortuitum following excision of a sebaceous cyst in Taiwan.
Tsai SC; Chen LH; Liao HH; Chiang CY; Lin WL; Chen SC; Tsao SM; Hung HC; Lee YT
J Infect Dev Ctries; 2016 Dec; 10(12):1357-1361. PubMed ID: 28036317
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of postlaparotomy wound infection caused by
Nagmoti MB; Kulgod SY; Narang R; Mulla RG
Int J Mycobacteriol; 2019; 8(4):400-402. PubMed ID: 31793513
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous infection with Mycobacterium fortuitum: an unusual presentation.
Sarma S; Thakur R
Indian J Med Microbiol; 2008; 26(4):388-90. PubMed ID: 18974500
[TBL] [Abstract][Full Text] [Related]
9. Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria.
Kodana M; Tarumoto N; Kawamura T; Saito T; Ohno H; Maesaki S; Ikebuchi K
J Infect Chemother; 2016 Jan; 22(1):32-5. PubMed ID: 26603481
[TBL] [Abstract][Full Text] [Related]
10. A totally implantable venous access port associated with bloodstream infection caused by Mycobacterium fortuitum: A case report.
Ye H; Zeng J; Qin W; Yang Z; Yang L; Wu Z; Du G
Medicine (Baltimore); 2018 Jul; 97(29):e11493. PubMed ID: 30024528
[TBL] [Abstract][Full Text] [Related]
11. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Hu FR; Luh KT
Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium chelonae and Mycobacterium fortuitum infection following open fracture: a case report and review of the literature.
Kwan K; Ho ST
Indian J Med Microbiol; 2010; 28(3):248-50. PubMed ID: 20644316
[TBL] [Abstract][Full Text] [Related]
13. A case of postoperative breast infection by Mycobacterium fortuitum associated with the hospital water supply.
Jaubert J; Mougari F; Picot S; Boukerrou M; Barau G; Ali Ahmed SA; Raskine L; Camuset G; Michault A; Simac C; Cambau E
Am J Infect Control; 2015 Apr; 43(4):406-8. PubMed ID: 25838135
[TBL] [Abstract][Full Text] [Related]
14. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
Serra C; Loi G; Saddi B; Pautasso M; Manzin A
J Clin Microbiol; 2007 May; 45(5):1663-5. PubMed ID: 17360837
[TBL] [Abstract][Full Text] [Related]
15. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.
Schinsky MF; Morey RE; Steigerwalt AG; Douglas MP; Wilson RW; Floyd MM; Butler WR; Daneshvar MI; Brown-Elliott BA; Wallace RJ; McNeil MM; Brenner DJ; Brown JM
Int J Syst Evol Microbiol; 2004 Sep; 54(Pt 5):1653-1667. PubMed ID: 15388725
[TBL] [Abstract][Full Text] [Related]
16.
Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
[TBL] [Abstract][Full Text] [Related]
17. Nasal infection due to Mycobacterium fortuitum.
Nguyen DQ; Righini C; Darouassi Y; Schmerber S
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Sep; 128(4):197-9. PubMed ID: 21596645
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium fortuitum infection associated with achalasia.
Bouchentouf R
Tunis Med; 2018 May; 96(5):311-313. PubMed ID: 30430507
[TBL] [Abstract][Full Text] [Related]
19. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium fortuitum and Mycobacterium abscessus infections in the foot and ankle in two immunocompetent patients.
Wong KP; Tang ZH; Tan GM
Biomedicine (Taipei); 2020; 10(4):52-56. PubMed ID: 33854936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
